In the BioHarmony Drug Report Database
Halofantrine
Halfan (halofantrine) is a small molecule pharmaceutical. Halofantrine was first approved as Halfan on 1992-07-24. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA. It is known to target potassium voltage-gated channel subfamily H member 2.
Trade Name
|
Halfan |
|---|---|
Common Name
|
halofantrine |
ChEMBL ID
|
CHEMBL1107 |
Indication
|
falciparum malaria, malaria, vivax malaria |
Drug Class
|
Image (chem structure or protein)